#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dermatomyositis Facioscapulohumeral muscular dystrophy Peripheral T-cell lymphoma unspecified Autoinflammation with infantile enterocolitis Myelodysplastic syndrome with excess blasts Oesophageal adenocarcinoma stage II Systemic candida Anti-HLA antibody test positive Retinal dystrophy Immunoglobulin G4 related disease Retinopathy of prematurity Marginal zone lymphoma Adrenoleukodystrophy Epilepsy with myoclonic-atonic seizures Progressive multifocal leukoencephalopathy More trials…

    Learn about Rare Diseases

    Congenital generalised lipodystrophy – Diagnostics Inclusion body myositis – Trials in Disease Progressive multifocal leukoencephalopathy – Treatment Alport’s syndrome – Trials in Disease Mucous membrane pemphigoid Osteosarcoma recurrent – Treatment Mucopolysaccharidosis III – Basic Information Optic glioma – Treatment Gaucher’s disease type III – Life with Disease Alveolar rhabdomyosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Salmeterol Xinafoate Midazolam Hydrochloride DCC-3084 Erythromycin Lactobionate CEFTAROLINE FOSAMIL ANUMIGILIMAB Tenofovir Alafenamide Fluconazole Dosulepin Hydrochloride GSK4418959A Avutometinib PF-07868489 Fenebrutinib Propofol Ict01 Adrc001 AGA2118 Zalunfiban Ofloxacin Cilazapril More therapies…

    Learn about Your Condition

    Niemann-Pick disease Pre-eclampsia Ventricular extrasystoles Vulvovaginal discomfort Intestinal obstruction Atrial septal defect Latent tuberculosis Polymyalgia rheumatica Head and neck cancer Chronic hepatic failure Vascular graft thrombosis Acute respiratory failure Osteosarcoma recurrent Henoch-Schonlein purpura Ventricular fibrillation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on the Safety and Tolerability of Tamoxifen in Cystic Fibrosis Patients Not Eligible for CFTR Modulator Therapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cystic fibrosis
    Investigated Drugs:
    • Tamoxifen
    Italy

  • Study of Valemetostat Tosylate with Drug Combination for Patients with Previously Treated Solid Tumors

    Not yet recruiting

    1 1 1
    Investigated Drugs:
    • Valemetostat Tosilate
    • Datopotamab Deruxtecan
    • Trastuzumab Deruxtecan
    France Italy Spain

  • Study on the Safety and Effectiveness of Budoprutug in Patients with Immune Thrombocytopenia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • BUDOPRUTUG
    Bulgaria Greece Spain

  • Study of Pembrolizumab for Patients with Stage IIb/c Melanoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma stage II
    Investigated Drugs:
    • Pembrolizumab
    • Sodium Chloride
    Sweden

  • Study on the Effects of Psilocybin for Young Adults with Anorexia Nervosa

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    Sweden

  • Study on Ulcerative Colitis: Evaluating Early Treatment with Adalimumab for Patients with Severe Symptoms

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    Norway
Previous Page
1 … 783 784 785 786 787 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!